# The Advisor Pro Direct Study

> **NCT03774069** · NA · TERMINATED · sponsor: **Rabin Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** DreaMed Advisor Pro
- **OTHER:** Medical guided recommendation

## Key facts

- **NCT ID:** NCT03774069
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** It was finally decided not to perform the interventional part of the study. Only the questionnaire's part was performed
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774069, "The Advisor Pro Direct Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03774069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*